ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 125.16

-1.1%

9:48 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HerbVic	2/16/2004 9:27:14 AM
	of 33

Abbott’s Next Test: Winning Back Clients By Sarah A. Klein WBBM Newsradio Abbott Laboratories finally has a green light to sell all of its diagnostic tests in the U.S., but persuading customers to use them again won't be easy. Since 1999, the U.S. Food and Drug Administration (FDA) banned Abbott, once the dominant player in diagnostics, from selling some of its tests. Abbott's rivals in that time snagged customers, contracts and sales staff. Many customers switched to F. Hoffman-LaRoche Ltd., Germany's Bayer AG, Johnson & Johnson and others. For them, switching back to Abbott equipment could be costly. Even worse: Some ex-customers are happy to be rid of Abbott. "I am going to get rid of everything and anything that Abbott currently has in my lab," says Ronald W. McLawhon, director of regional laboratory services for the University of Chicago Hospitals on the South Side. Mr. McLawhon says he was frustrated by Abbott even before the FDA ban. He cites broken promises, poor communication and supply shortages stemming from Abbott's long-running clash with the FDA. <snip> wbbm780.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next